Urinary infection in patients with chronic renal failure on hemodialysis. 1987

G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
County Hospital, Institute of Medicine, Timişoara, Romania.

A group of 37 hemodialyzed patients with chronic renal failure were investigated within a period of 6 months to 9 years. Of these patients five presented quantitatively significant bacteriuria noncorrelated with the causal nephropathy. Of the 9 patients with urologic past history two presented urinary infection. Urinary bacterial immunofluorescence was constantly positive in all the cases in which bacteriuria was significant and, at least in one determination when the germ count was below 10,000/ml. This finding was also supported by the increase of gammaglobulinemia and of the circulating immune complexes in all the cases investigated as well as of the B lymphocytes in one third of cases. Fifty percent of the patients presented T lymphocytopenia with excess of suppressor lymphocytes and deficit of the helper ones. It can, therefore be assumed that in patients with chronic renal failure nondialyzable antigens persist in the renal parenchyma where they stimulate anticorpogenesis but at a low level owing to some immune disturbances present in such patients.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
June 1985, The Journal of urology,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
January 2003, Journal of nephrology,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
January 2006, Indian journal of dermatology, venereology and leprology,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
January 2014, International journal of immunopathology and pharmacology,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
December 2012, Cutaneous and ocular toxicology,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
August 1975, Annals of internal medicine,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
April 1979, Revista clinica espanola,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
January 2005, Klinicheskaia meditsina,
G Gluhovschi, and O Golea, and A Schiller, and P Arcan, and I Drăgan, and A K Nasem, and N Barbu
December 1987, Journal of clinical gastroenterology,
Copied contents to your clipboard!